| Literature DB >> 16822311 |
Cynthia de la Fuente1, Madhur V Gupta, Zachary Klase, Katharine Strouss, Patrick Cahan, Timothy McCaffery, Anthony Galante, Patricia Soteropoulos, Anne Pumfery, Masahiro Fujii, Fatah Kashanchi.
Abstract
BACKGROUND: Adult T-cell leukemia (ATL) is a complex and multifaceted disease associated with human T-cell leukemia virus type 1 (HTLV-I) infection. Tax, the viral oncoprotein, is considered a major contributor to cell cycle deregulation in HTLV-I transformed cells by either directly disrupting cellular factors (protein-protein interactions) or altering their transcription profile. Tax transactivates these cellular promoters by interacting with transcription factors such as CREB/ATF, NF-kappaB, and SRF. Therefore by examining which factors upregulate a particular set of promoters we may begin to understand how Tax orchestrates leukemia development.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16822311 PMCID: PMC1553470 DOI: 10.1186/1742-4690-3-43
Source DB: PubMed Journal: Retrovirology ISSN: 1742-4690 Impact factor: 4.602
Figure 1Aneuploidy in CTLL/WT cells. CTLL/WT and CTLL/703 cells were treated with 10 μg/ml colcemid, centrifuged, and resuspended in hypotonic solution to swell the cells. Cells were then fixed and dropped onto slides. After being stained with Giemsa and dried, slides were analyzed using the Olympus BX-60 microscope. A total of 35 metaphase spreads were counted. Representative chromosome spreads of CTLL/WT (panel A) and CTLL/703 (panel B) are displayed with 100 and 42 chromosomes, respectively. Panels C) and D) are graphical representations of the raw counts from these two cell types.
Figure 2Overview of microarray analysis, annotation, and promoter analysis. A schematic depicting the workflow of the project. Gene expression analysis of CTLL/WT and CTLL/703 cells was performed utilizing the Affymetrix's Murine Genome U74A GeneChip. Genes that were either up-or down-regulated in CTLL/WT cells by a magnitude of at least two-fold were functionally annotated using NIH's DAVID bioinformatics program. Next, promoter sequences (2100 bp surrounding the predicted TSS) were retrieved from PromoSer. One third of the promoter sequences retrieved were checked for proper alignment against the mouse genome using Blastn and MapViewer tools through NCBI. CREB (TGACGT/C, A/GGGAGT) consensus sequences were obtained through TRANSFAC database and searched within the promoters obtained. Factors that contained the CREB sequences within their promoters were further probed for genes that contribute directly to mitosis, cytokinesis, and microtubule organization.
Cellular genes containing CREB response element activated by Tax
| Apaf1 | a po pto tic protease activating factor 1 | 2.5 | ||||||||||
| Arf1 | ADP-ribosylation factor 1 | 2.6 | ||||||||||
| Atp5c1 | ATP synthase, H+ transporting, m itochondrial F1 com plex, gam m a polypeptide 1 | 2.1 | ||||||||||
| Atp6v0c | ATPase, H+ transporting, V0 subunit C | 2.3 | ||||||||||
| Ccrn4l | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 2.1 | ||||||||||
| Cetn3 | centrin 3 | 2.2 | ||||||||||
| Chek1 | checkpoint kinase 1 hom olog (S. pom be) | 2.3 | ||||||||||
| Cox5b | cytochrom e c oxidase, subunit Vb | 2.3 | ||||||||||
| Cpe | carboxypeptidase E | 17.3 | ||||||||||
| Dld | dihydrolipoam ide dehydrogenase | 2.4 | ||||||||||
| Ebf1 | early B-cell factor 1 | 2.9 | ||||||||||
| Fdx1 | ferredoxin 1 | 4.3 | ||||||||||
| Sm c2l1 | SM C2 structural m aintenance of chrom osom es 2-like 1 (yeast) | 2.8 | ||||||||||
| Lpin1 | lipin 1 | 2.4 | ||||||||||
| Fth | ferritin heavy chain | 2.4 | ||||||||||
| Gabrr1 | gam m a-am inobutyric acid (GABA-C) receptor, subunit rho 1 | 2.3 | ||||||||||
| Gja1 | gap junction m em brane channel protein alpha 1 | 7.4 | ||||||||||
| Gnai3 | guanine nucleotide binding protein, alpha inhibiting 3 | 2.0 | ||||||||||
| Grcc10 | gene rich cluster, C10 gene | 2.2 | ||||||||||
| Hspa5 | heat shock 70kD protein 5 (glucose-regulated protein) | 3.0 | ||||||||||
| Guk1 | guanylate kinase 1 | 4.2 | ||||||||||
| H2-Aa | histocom patibility 2, class II antigen A, alpha | 3.8 | ||||||||||
| H2-Ab1 | histocom patibility 2, class II antigen A, beta 1 | 3.1 | ||||||||||
| H2-D1 | histocom patibility 2, D region locus 1 | 2.7 | ||||||||||
| H2-DM b1 | histocom patibility 2, class II, locus M b1 | 2.5 | ||||||||||
| Hk2 | hexokinase 2 | 2.5 | ||||||||||
| Hspa9a | heat shock protein, A | 3.3 | ||||||||||
| Ier2 | im m ediate early response 2 | 2.9 | ||||||||||
| Junb | Jun-B oncogene | 2.0 | ||||||||||
| Psm b8 | proteosom e (prosom e, m acropain) subunit, beta type 8 (large m ultifunctional protea | 2.6 | ||||||||||
| M dh2 | m alate dehydrogenase 2, NAD (m itochondrial) | 3.4 | ||||||||||
| Nfkbib | nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, beta | 2.6 | ||||||||||
| Pld3 | phospholipase D3 | 2.4 | ||||||||||
| Ppp1cb | protein phosphatase 1, catalytic subunit, beta isoform | 2.5 | ||||||||||
| Psm b5 | proteasom e (prosom e, m acropain) subunit, beta type 5 | 2.3 | ||||||||||
| Psm e3 | proteasom e (prosom e, m acropain) 28 subunit, 3 | 2.2 | ||||||||||
| Dusp1 | dual specificity phosphatase 1 | 8.1 | ||||||||||
| Pura | purine rich elem ent binding protein A | 2.4 | ||||||||||
| Rab6 | RAB6, m em ber RAS oncogene fam ily | 2.4 | ||||||||||
| Rgs2 | regulator of G-protein signaling 2 | 2.5 | ||||||||||
| Ccl1 | chem okine (C-C m otif) ligand 1 | 0.3 | ||||||||||
| Glg1 | golgi apparatus protein 1 | 2.4 | ||||||||||
| Slc31a1 | solute carrier fam ily 31, m em ber 1 | 2.9 | ||||||||||
| Srp14 | signal recognition particle 14 | 2.5 | ||||||||||
| Tnfrsf9 | tum or necrosis factor receptor superfam ily, m em ber 9 | 4.2 | ||||||||||
| Plscr1 | phospholipid scram blase 1 | 5.2 | ||||||||||
| Ubl1 | ubiquitin-like 1 | 2.3 | ||||||||||
| Vwf | Von W illebrand factor hom olog | 2.3 | ||||||||||
| Ywhah | tyrosine 3-m onooxygenase/tryptophan 5-m onooxygenase activation protein, eta po | 2.0 | ||||||||||
| Zap70 | zeta-chain (TCR) associated protein kinase | 2.6 | ||||||||||
| Cfdp | craniofacial developm ent protein 1 | 2.1 | ||||||||||
| Psm b2 | proteasom e (prosom e, m acropain) subunit, beta type 2 | 2.3 | ||||||||||
| Casp8ap2 | caspase 8 associated protein 2 | 2.3 | ||||||||||
| H2afy | H2A histone fam ily, m em ber Y | 2.1 | ||||||||||
| Atp5o | ATP synthase, H+ transporting, m itochondrial F1 com plex, O subunit | 2.5 | ||||||||||
| Tax1bp1 | Tax1 (hum an T-cell leukem ia virus type I) binding protein 1 | 2.3 | ||||||||||
| Hnrpa2b1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 2.5 | ||||||||||
| Dctn3 | dynactin 3 | 2.4 | ||||||||||
| Zfp265 | zinc finger protein 265 | 2.1 | ||||||||||
| Rragc | Ras-related GTP binding C | 2.7 | ||||||||||
| Uchl5 | ubiquitin carboxyl-term inal esterase L5 | 2.3 | ||||||||||
| Dstn | destrin | 2.6 | ||||||||||
| Gabarap | gam m a-am inobutyric acid receptor associated protein | 2.1 | ||||||||||
| Asna1 | arsA (bacterial) arsenite transporter, ATP-binding, hom olog 1 | 2.2 | ||||||||||
| Park7 | Parkinson disease (autosom al recessive, early onset) 7 | 2.1 | ||||||||||
| Isg20 | interferon-stim ulated protein | 4.8 | ||||||||||
| Vps35 | vacuolar protein sorting 35 | 2.3 | ||||||||||
| Cyc1 | cytochrom e c-1 | 2.2 | ||||||||||
| Usm g5 | upregulated during skeletal m uscle growth 5 | 2.2 | ||||||||||
| Sdhb | succinate dehydrogenase com plex, subunit B, iron sulfur (Ip) | 2.5 | ||||||||||
| Sugt1 | SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) | 2.3 | ||||||||||
| Ndufb2 | NADH dehydrogenase (ubiquinone) 1 beta subcom plex, 2 | 2.3 | ||||||||||
| Ubap2 | ubiquitin-associated protein 2 | 2.1 | ||||||||||
| St13 | suppression of tum origenicity 13 | 2.1 | ||||||||||
| Csnk1a1 | casein kinase 1, alpha 1 | 2.5 | ||||||||||
| Klf7 | Kruppel-like factor 7 (ubiquitous) | 2.7 | ||||||||||
| Rars | arginyl-tRNA synthetase | 2.7 | ||||||||||
| Ppp1r15b | protein phosphatase 1, regulatory (inhibitor) subunit 15b | 2.0 | ||||||||||
| Gus | beta-glucuronidase | 2.6 | ||||||||||
| Atp6v0b | ATPase, H+ transporting, V0 subunit B | 2.5 | ||||||||||
| Lactb2 | lactam ase, beta 2 | 2.0 | ||||||||||
| Appbp1 | am yloid beta precursor protein binding protein 1 | 2.1 | ||||||||||
| Aars | alanyl-tRNA synthetase | 2.3 | ||||||||||
| Eif2c2 | eukaryotic translation initiation factor 2C, 2 | 2.6 | ||||||||||
| p97(Vcp) | valosin containing protein | 3.0 | ||||||||||
| Flnb | filam in, beta | 31.9 | ||||||||||
| 9 Unknowns: | ||||||||||||
Tax activated genes involved in aneuploidy
| Arf1 | ADP-ribosylation factor 1 | 2.6 | Membrane vesicle formation, inactivation nec. for mitotic Golgi breakdown, chromosome segregation, and cytokinesis [95–97] | |
| Cetn3 | centrin 3 | 2.2 | spindle cell body duplication need for bipolarity in cytokinesis [98–103] | |
| Chek1 | checkpoint kinase 1 homolog (S. pombe) | 2.3 | needed for S and G2 checkpoints after DNA damage; Tax has been shown to disrupt its function [24,25,104–106] | |
| Dctn3 | dynactin 3 | 2.4 | light-chain subunit of dynactin complex (p24); dynactin complex involved in vesicle movement; dynactin complex interacts with NuMA and dynein in order to tether microtubules at the spindle poles and that are essential for mitotic spindle pole assembly and stabilization; recruitment by ZW10 protein to the kinetichore [107–110] | |
| p97(Vcp) | valosin containing protein | 3.0 | aka cdc48; needed for spindle disassembly after segregation; Golgi disassembly-assembly [111–113] | |
| Ppp1cb | protein phosphatase 1, catalytic subunit, beta isoform | 2.5 | antagonist of Aurora B kinase during mitosis, i.e. regulating the protein interface between the centromeres and the mitotic spindle; possible downstream targets include kinetochore protein Ndc10, CENP-A, which substitutes for histone H3 in centromeric nucleosomes, and inner centromere protein INCENP; mutation of PP1 or inactivation was shown to result in cytokinesis defects. [114] | |
| Pura | purine rich element binding protein A | 2.4 | involved in DNA replication and transcription; overexpression results in G2 blockage [115,116] | |
| Smc2l1 | SMC2 structural maintenance of chromosomes 2-like 1 (yeast) | 2.8 | aka CAP-E protein, that is part of the condensin protein complex originally identified in Xenopus; protein complex is needed for chromosome condensation; CAP-E has been found to interact with DNA ligase IV (DNA double-strand break repair protein) possible interaction important for genome stability [117–120] | |
| Sugt1 | SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) | 2.3 | recent study shows that SGT1 is needed for kinetechore assembly [66,76] | |
| Ywhah | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 2.0 | binds to CDC25B in a phosphorylation independent mechanism [121,122] | |
| Zwint-1 | ZW10 interactor | 2.1 | specifies the kinetochore association of ZW10 which may act as part of, or immediately downstream of, the wait anaphase tension-sensing checkpoint [123,124] |
Figure 3Recruitment of CREB and basal transcription machinery at the Sgt1 and p97/Vcp promoters. A) Presence of Pol II on Sgt1 promoter. ChIP analysis of Sgt1 promoter using IgG, anti- H3S10, and anti- Pol II antibodies (α-RNAP II, Santa Cruz, polyclonal rabbit #N-20)compared to input (lanes 1, 2, 3 and 5, respectively). IgG and beads only (lanes 1 and 4) were used as negative controls. Top panel corresponds to typical results from CTLL/WT cells, while the bottom panel corresponds to results from CTLL/703 cells. B) Presence of CREB and Pol II on Sgt1 and p97 promoters. ChIP analysis of Sgt1 and p97/Vcp promoters using antibodies against CREB, p-CREB and Pol II (lanes 2, 3 and 4). The Pol II antibody recognizes the phosphorylated elongating Pol II complex (α-Ser 2P CTD (H5, Covance)). IgG and Beads alone (lanes 1 and 5) were used as negative controls.
Figure 4Sgt1 and p97 ChIP results. A) and B) are the graphical representations of the Sgt1 and p97 ChIP results obtained from CTLL/WT and CTLL/703 cells shown in Figure 3 (Average of two experiments).
Figure 5Effect of Tax on Sgt1 and p97 protein levels. A) One hundred microgram of total cell extracts from human (CEM and C81) and mouse (CTLL/WT and CTLL/703) cells were prepared and ran on a 4–20% SDS PAGE. All three C81, CTLL/WT, CTLL/703 express Tax and CEM served as a negative control. Western blots were with anti-Sgt1 (1:1000), anti-p97 (1:500) and anti-actin (1:5000) antibodies. Two forms of Sgt1 (A and B) were observed in human cells, where the A form is wild type protein and B form is the splice variant. B) Five microgram of either wild type or M47 Tax was transfected into CEM (5x106/sample) cells. Following transfection cells were kept at 37°C for 48 hrs, followed by preparation of total extract and processed for western blot using a 4–20% SDS-PAGE. Similar antibodies as in panel A were used for the western blot and immune complexes were detected using ECL.
Figure 6Effect of Tax on cellular promoters and its protein-protein interaction.A) Chromatin immunoprecipitation experiments were used to test whether Tax could occupy Sgt1 or p97 promoters. CTLL/WT and CTLL/703 (7.5 × 106 cells/ChIP), as well as C81 (Tax expressing, 5.5 × 106 cells/ChIP) and CEM (negative control with no Tax expression, 5.5 × 106 cells/ChIP) were cross-linked, and processed for ChIP assay. Lanes 1, 4, 7 and 10 are "input" lanes where no immunoprecipitation was performed prior to PCR (positive control). Lanes 3, 6, 9 and 12 contained no antibody, and only beads, for the immunoprecipitation (negative control). Lanes 2, 5, 8 and 11 used a mixture of 500 ng of each TAb anti-Tax monoclonal antibodies (169, 170, 171 and 172; amount of each antibody judged by running 100 ng of each purified antibody on 4–20% SDS-PAGE and stained for Heavy and light chains) as the experimental sample. The high salt wash step after immunoprecipitation contained 1000 mM (as opposed to 500 mM) salt. B) Two set of C81 cells were used for immunoprecipitation followed by western blot against Tax. First, unsynchronized C81 cells (2 mg total cellular extract, Lanes 1–6) where majority of cells were at the G1 phase (71%), were used for immunoprecipitation with anti-Sgt1 (1 μg), anti-p97 (1.2 μg), anti-cdk2 (0.75 μg) and IgG (1.2 μg) followed by western blot with anti-Tax polyclonal antibody. We have previously used this method to define a list of Tax binding proteins using low and high salt wash conditions [69]. We also enriched C81 cells for G2/M population (67%) by treating with low serum (1%) and nocodazole (Noco, 50 ng/ml) for 72 hrs prior to the immunoprecipitation [15]. Lanes 4, 5, 10 and 11 served as negative control for IP, and lanes 3 and 9 served as positive control for Tax binding protein under high salt conditions (cdk2). Lanes 6 and 12 were total cellular extract (Input, 50 μg) and lanes 1, 2, 7 and 8 served as the experimental sample. The high salt wash after immunoprecipitation contained 1000 mM salt.
Primers used for PCR
| Arf1 | ACCCTTGCTCGTTCTAGTGC | GGTTTCGCTCCCACAAGAT | 224 | Yes | |
| Chek1 | CCACCACACTTGCTTTCCTT | GGAATCCAAATGCACAGCTT | 583 | Yes | |
| Dctn3 | TTTGGGTGTACGTCCTGACA | CAGCTCCTCCACTCGAGACT | 486 | Yes | |
| p97(Vcp) | ATTGCCTTTGTCGATTGGTC | TCGGAAGGAAAGCTGCTCTA | 228 | Yes | |
| Ppp1cb | AGCAGGGAAGGAAGGTCATT | GGCGTTCTCACCTACGAGTC | 529 | Yes | |
| Smc2l1 | CTTACAGCCGTTTGCCTAGC | CCGTTTTGAACATGGAAAGC | 439 | Yes | |
| Sgt1 | AGCCGACTTAGGAAGGAAGC | GTCTCGGAGCCCACTGTAAG | 325 | Yes | |
| Ywhah | AGGTCCCCGTAGGTATGTCC | CCCAGCCCTAACGGTCTT | 507 | Yes |